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Abstract
Background: Sexually transmitted infections constitute the main health risk among adolescents. In developing
countries the diagnosis and treatment of cervical infections is based on the syndromic approach. In this study we
estimated the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among female adolescents from a
Health Sector of the city of Goiânia, Brazil, and validated cervicitis diagnosis using World Health Organization/
Ministry of Health risk score and gynecological examination.
Methods: A cross-sectional community-based sample of 914 15- to 19-year-old female teenagers was randomly
selected and referred to the local Family Health Program. Of these, 472 (51.6%) were sexually active and
gynecological examinations were carried out for 427. Endocervical samples were collected to perform the
polymerase chain reaction for C. trachomatis and N. gonorrhoeae. Performance of risk score, the presence of
mucopurulent discharge, friability, ectopia and pain during cervical maneuver were compared with the presence
of C. trachomatis or N. gonorrhoeae or both.
Results: The prevalence of C. trachomatis and N. gonorrhoeae was 14.5% and 2.1%, respectively. The risk score
had a specificity of 31.9% (95% confidence interval, 21.2 to 44.2) and a positive predictive value of 20.8% (95%
confidence interval, 13.5 to 29.7). Friability was the component of the gynecological examination that presented
the best performance with a sensitivity of 43.5%, specificity of 81.0%, and 30.6% of positive predictive value.
Conclusion: The prevalence of infection by C. trachomatis and N. gonorrhoeae was high among these sexually
active adolescents. The syndromic approach is clearly inadequate for screening and treating these infections in
this population. Therefore, the implantation of other strategies to control these infections among adolescents is
urgently required.
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Background
Sexually transmitted infections (STI) constitute the main
health risk among sexually active adolescents [1], as con-
firmed by data from developed countries where statistical
systems are well-organized. In the United States and Euro-
pean countries the infection rates of Chlamydia trachoma-
tis, Neisseria gonorrhoeae and human papillomavirus are
highest among adolescents and young adults up to 24
years old [2,3]. In addition, it is well recognized that STI
may increase the likelihood of human immunodeficiency
virus (HIV) transmission as much as 20-fold [4]. In devel-
oping countries, including Brazil, although available data
are scarce, these trends were confirmed [5,6].
Sexually active adolescents should be adequately targeted
for prevention and treatment of STI by early screening
strategies [7]. However, in many developing countries,
especially those in Africa [8], where the acquired immune
deficiency syndrome (AIDS) epidemic has reached cata-
strophic proportions, lack of adequate diagnostic
resources jeopardize this strategy. The World Health
Organization (WHO) has proposed a syndromic
approach for screening and treating STI, which uses algo-
rithms favoring specific symptoms such as urethral dis-
charge, the presence of ulcers and abnormal vaginal
discharge [9]. The first two have proven to be efficacious
for treatment purposes [10-12]. However, the algorithm
abnormal vaginal discharge, which has been validated in
several studies, is currently criticized, especially because
the most prevalent STI are frequently asymptomatic
[13,14]. In addition, this algorithm has never been vali-
dated in Brazil in an exclusively adolescent population;
such validation is also rare worldwide [15,16]. The aim of
the present study was to validate the diagnosis of cervicitis
due to C. trachomatis and N. gonorrhoeae using the WHO/
Ministry of Health risk score and gynecological examina-
tion in a population-based sample of female adolescents
in Brazil.
Methods
Setting and study design
The study was a population-based cross-sectional study of
sexually active female adolescents resident in the North-
eastern Health Sector of Goiânia, a city with 1,129,274
inhabitants in the central region of Brazil. The overall
population of this sector was 11,389 inhabitants, with an
estimated total of 4091 15 to 19-year-old female adoles-
cents attending a Family Health Program.
The sample size was estimated as 588 female sexually
active adolescents, 15 to 19 years old, considering a 1.5%
precision, minimum expected STI prevalence of 4%, and
an anticipated refusal rate of 10%. Households with
potential participants were randomly selected from cen-
sus tract information provided by the local health depart-
ment using a systematic sampling scheme.
All female adolescents in each selected household were
invited by letter to come to the health center nearest to
their residence. At the health center, they were informed
about the study, and were initially interviewed by a physi-
cian trained in adolescent medicine or a trained nurse,
using a questionnaire containing sociodemographic and
general health-related questions, including the onset of
sexual activity. Those sexually active were invited for fur-
ther procedures, including a gynecological examination,
while those who were sexually inactive were counseled
concerning general health issues or referred for a medical
appointment and/or vaccination whenever necessary.
Adolescents who had used antimicrobial drugs within the
previous 15 days as well as pregnant women were
excluded from enrollment. Those eligible adolescents
were requested to sign a written informed consent and the
study was approved by the Ethical Review Board from the
University Hospital, Federal University of Goiás after
proper authorization by Goiânia City Health Department.
Interviews were carried out in private rooms and confi-
dentiality was assured.
Gynecological examination
Sexually active adolescents were referred to a physician for
a gynecological examination. They also answered a more
specific questionnaire concerning sexual practices, repro-
ductive life and gynecological symptoms. The risk score
was then determined based on the following items: part-
ner with urethral discharge, 2 points; age less than 20
years-old, 1 point; more than one partner in the last three
months, 1 point; new partner in the last three months, 1
point; no fixed partner, 1 point. The risk score was consid-
ered positive when equal to or greater than 2 points [11].
An examination of the abdomen, external and internal
genitalia, followed by a speculum examination was per-
formed on each subject. After cleaning the ectocervix,
material was collected by introducing a swab into the
endocervix and then rotating for 5 seconds before careful
removal. Samples were immediately placed in a polymer-
ase chain reaction (PCR) transportation tube for PCR test-
ing for C. trachomatis and  N. gonorrhoeae. The
gynecological examination data assessed for validation of
a diagnosis of cervicitis were those proposed by the Min-
istry of Health: mucopurulent endocervical discharge, cer-
vical friability and pain upon bimanual maneuver of the
cervix, plus the presence of ectopia.
Laboratory method
The samples for PCR testing were transported to the Cel-
lular Immunology Laboratory of the Institute of TropicalBMC Medicine 2009, 7:8 http://www.biomedcentral.com/1741-7015/7/8
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Pathology and Public Health of the Federal University of
Goiás, Brazil. PCR for C. trachomatis and N. gonorrhoeae
were carried out by the CT/NG Amplicor kit (Roche
Molecular Systems, Branchburg, NJ, USA) according to
the manufacturer's instructions using standard proce-
dures. Internal controls were used in all amplifications.
Data management and analysis
The prevalence of C. trachomatis and N. gonorrhoeae infec-
tions and their respective 95% confidence intervals (95%
CI) were estimated as the number positive in each PCR
test divided by the total number of adolescents tested.
Sensitivity, specificity, positive predictive value (PPV),
negative predictive value, with their respective 95% CI
were estimated to determine the ability of risk score and
gynecological examination components to differentiate
between those infected with either C. trachomatis or N.
gonorrhoeae and those uninfected cases. PCR results for
both infections were the gold standard for comparisons.
Differences in proportion were assessed using Fisher's
exact test. Data were analyzed using Epi Info, version 6.0
(CDC, Atlanta, GA, USA).
Results
In order to achieve the necessary sample size, 1539 female
adolescents belonging to the randomly selected house-
holds were invited for a medical visit at their nearest
health unit. From August 2002 to September 2003, 914
(60.0%) adolescents aged 15 to 19 years attended the
health units and were eligible for the study. The main rea-
son for not responding was a change of address (N = 335),
while 166 were not eligible due to age criteria, 89 were
pregnant and 35 had other reasons.
Among the 914 adolescents who fulfilled the inclusion
criteria and gave informed consent 472 (51.6%) were sex-
ually active and 427 (90.5%) of these had a gynecological
examination performed, including the collection of mate-
rial for the diagnosis of a chlamydial and gonococcal
infection. Only four teenagers refused to participate in the
study and 41 were excluded because they were menstruat-
ing or had used oral medications or vaginal topical antibi-
otics in the last 15 days.
Sociodemographic data indicated a uniform distribution
across ages (mean age = 17.2 ± 1.3 years), and revealed
that an important proportion of these teenagers were
already married or living with partners (32.1%). Most of
them had between 5 and 8 years of schooling, had poorly
educated mothers and low family income (Table 1)
The WHO/Ministry of Health risk score and gynecological 
examination data
The prevalence of infection with C. trachomatis was expres-
sively high (14.5%; 95% CI 11.4 to 18.3), while the prev-
alence of N. gonorrhoeae was markedly lower (2.1%; 95%
CI 1.0 to 4.1). Only two adolescents presented with a
simultaneous C. trachomatis and N. gonorroeae infection.
Overall, 69 (16.2%) adolescents were positive for C. tra-
chomatis and/or N. gonorrhoeae while the risk score (≥ 2
points) was positive in 106 (24.8%; 95% CI 20.8 to 29.2)
subjects. The majority (64.1%) of adolescents with a pos-
itive risk score had only 2 points. The frequency of a pos-
itive risk score, pain upon bimanual maneuver, ectopia,
friability or mucopurulent discharge was higher in those
subjects positive for an STI (Table 2). However, only pain,
friability and mucopurulent discharge were statistically
different between groups (P < .05).
The performance of the risk score and gynecological
examination data regarding cervical infection diagnosis is
described in Table 3. Sensitivity of the WHO risk score
algorithm was 31.9%, that is, only 22 out of 69 women
with a cervical infection were correctly identified. The spe-
cificity was 76.5% and the PPV was 20.8%, that is, 20.8%
of those identified by the WHO risk score actually had a
cervical infection. Friability was the component of the
gynecological examination that presented the best per-
formance with a sensitivity of 43.5%, specificity of 81.0%
Table 1: Sociodemographic characteristics of 427 sexually active 
adolescents resident in the Northeastern Health Sector of 
Goiânia, Goiás, Brazil, in 2003.
Variables N %
Age (years old)
15 54 12.6
16 86 20.1
17 93 21.8
18 108 25.4
19 86 20.1
Marital status
Single 290 67.9
Married/cohabiting 137 32.1
Schooling (years)
<5 19 4.5
5 to 8 224 52.5
>8 183 42.8
not available 1 0.2
Mother's schooling (years)
None 37 8.7
<5 183 42.8
5 to 8 145 34.0
>8 39 9.1
not available 23 5.4
Family income (minimum wages)
<2 MWs 200 46.8
2 to 4 MWs 155 36.3
>4 MWs 48 11.3
not available 24 5.6
MW = 153 US$BMC Medicine 2009, 7:8 http://www.biomedcentral.com/1741-7015/7/8
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and 30.6% of PPV. Finally, after testing for combinations
of clinical signs and risk score, there was no indication of
improvement in sensitivity for detecting STI among these
female adolescents.
Discussion
This study was a community-based representative sample
of the female adolescent population, aged 15 to 19 years
old, residents of one of the most socially deprived regions
of the city of Goiânia. The prevalence of infection, partic-
ularly with C. trachomatis, was very high.
It is well known that adolescents present the highest prev-
alence levels of these infections in most countries [17,18].
Moreover, the fact that this population is one of low fam-
ily income and lower level of education further increases
the risk of STI [19,20].
In Brazil, recent data indicate that the fastest growing rate
of HIV infection is among adolescents aged 15 to 19 years-
old [21]. Thus, the control of STI is imperative, not only
because of their intrinsic complications, especially in rela-
tion to chlamydia and gonococcus infection among
female adolescents, but also due to their facilitating action
in relation to HIV infection [22-25].
STI screening programs in many developed and develop-
ing countries, including Brazil, are not fully implemented.
In the United States, for example, the Centers for Disease
Control recommend annual screening of chlamydia infec-
tion among sexually active female adolescents and young
adults up to 25 years of age, but this program is not widely
followed [26,27].
Despite the national and international recognition of the
Brazilian National AIDS Program, Brazil is lagging behind
other countries in regard to the detection and treatment of
other STI, including secondary prevention. Only recently,
a more clear priority has been given to implementing pub-
lic health policies for the control of STI, including chlamy-
dia and gonococcus infections. The current choice for STI
treatment adopted by the Ministry of Health is the use of
Table 2: Frequency of risk score and gynecological examination data among adolescents infected with Chlamydia trachomatis and/or 
Neisseria gonorrhoeae.
Variables C. trachomatis and/or N. gonorrhoeae positive N = 69
N (%)
No STI
N = 358
N (%)
Fisher's exact test
P value
Risk scorea
Positive 22 (31.9) 84 (23.5) .170
Pain upon bimanual maneuver
Yes 25 (36.2) 71 (19.8) .0044b
Ectopia
Yes 21 (30.4) 89 (24.9) .367
Friability
Yes 30 (43.5) 68 (19.0) <.0001c
Mucopurulent discharge
Yes 11 (15.9) 28 (7.8) .040d
aPositive risk score: ≥ 2 points.
bOdds ratio = 2.297, 95% confidence interval = 1.318, 4.003.
c Odds ratio = 3.281, 95% confidence interval = 1.903, 5.655.
d Odds ratio = 2.235, 95% confidence interval = 1.054, 4.738.
Table 3: Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value of the Risk Score and Gynecological 
Examination Data for Diagnosing Cervicitis by Chlamydia Trachomatis and/or Neisseria Gonorrhoeae.
Variables Sensitivity
% (95% CIa)
Specificity
% (95% CI)
PPVb
% (95% CI)
NPVc
% (95% CI)
Risk score 31.9 (21.2–44.2) 76.5 (71.7–80.8) 20.8 (13.5–29.7) 85.4 (81.0–89.0)
Pain upon bimanual maneuver 36.2 (25.6–48.7) 80.2 (75.6–84.2) 26.0 (17.6–36.0) 86.7 (82.6–90.2)
Ectopia 30.4 (19.9–42.8) 75.1 (70.3–79.5) 19.1 (12.2–27.7) 84.9 (80.5–88.6)
Friability 43.5 (31.5–56.0) 81.0 (76.6–84.9) 30.6 (21.7–40.7) 88.2 (84.2–91.5)
Mucopurulent discharge 15.9 (8.2–26.7) 92.2 (88.9–94.8) 28.2 (15.0–44.9) 85.1 (81.1–88.4)
CI: confidence interval
PPV: positive predictive value
NPV: negative predictive valueBMC Medicine 2009, 7:8 http://www.biomedcentral.com/1741-7015/7/8
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a syndromic approach for diagnosing and treating cervici-
tis, despite it being known that these infections are asymp-
tomatic in up to 80% of cases [28].
Our results indicate that the use of the risk score for cerv-
icitis screening and diagnosis among female adolescents is
not adequate due to the large proportion of asymptomatic
infections, most of which are positive for chlamydia. The
low sensitivity and low PPV of the risk score should be of
major public health concern. In addition, the risk score
does not appear to improve the management of cervical
infections, and should not be used as a screening tool or a
diagnostic test among asymptomatic or poorly sympto-
matic women [29,30]. Components of the gynecological
examination assessed for validation of a cervicitis diagno-
sis proposed by the Ministry of Health also had a poor
performance.
Conclusion
The prevalence of infection by C. trachomatis was alarm-
ingly high. The risk score proposed by the Ministry of
Health and the findings of gynecological examinations are
not adequate for the diagnosis and treatment of cervicitis
due to chlamydia and gonococcus infection in adoles-
cents. Therefore, other strategies to control these infec-
tions among adolescents are urgently required. Among
such strategies, emphasis must include investment in pri-
mary prevention through sexual education, which should
include the family, school, health services and sexual part-
ners. The 'reinvention' of sexual education is also a funda-
mental requirement, since the currently used methods,
while achieving increased awareness among young peo-
ple, especially regarding HIV infection, has not achieved
the desirable and essential level of a change in behavior
[31].
As far as secondary prevention is concerned, the develop-
ment of rapid and less costly tests for chlamydia and
gonococcus diagnosis in resource-poor public health serv-
ices are urgently needed. Studies regarding the prevalence
of chlamydia and gonococcus infection should be encour-
aged in other regions of Brazil so that improved clinical-
epidemiological diagnosis of this highly relevant public
health problem occurs at a national level, similar to devel-
oped countries.
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